News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
221 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17597)
Month
January (4450)
February (4428)
March (5683)
April (4545)
May (5703)
June (4805)
July (3912)
August (4762)
September (4260)
October (3860)
November (4837)
December (2683)
Day
1 (221)
2 (198)
3 (246)
4 (134)
5 (2)
6 (26)
7 (189)
8 (263)
9 (229)
10 (265)
11 (138)
12 (2)
13 (5)
14 (238)
15 (260)
16 (218)
17 (239)
18 (111)
19 (1)
20 (3)
21 (103)
22 (312)
23 (250)
24 (321)
25 (115)
26 (6)
27 (5)
28 (328)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
Drug Development
ANAVEX®2-73 (Blarcamesine) AVATAR Phase 3 Trial met Primary and Secondary Efficacy Endpoints for the Treatment of Adult Patients with Rett Syndrome
Anavex Life Sciences today reported positive top-line results from the Phase 3 randomized, double-blind, placebo-controlled AVATAR trial of ANAVEX®2-73
February 1, 2022
·
11 min read
Business
Nanoscope Therapeutics Announces Five New Clinical and Scientific Advisory Board Appointments
Nanoscope Therapeutics Inc today announced an expansion of its Clinical and Scientific Advisory Board with the appointment of five new members.
February 1, 2022
·
2 min read
Business
ImmuneID Appoints Jeremiah Degenhardt, Ph.D., as SVP Computational Biology
ImmuneID today announced the appointment of Jeremiah Degenhardt, Ph.D., as Senior Vice President, Computational Biology.
February 1, 2022
·
3 min read
Business
Drs. Margaret Dugan and Alessandro Riva Appointed to BeiGene Board of Directors
BeiGene today announced the appointment of Margaret Dugan, M.D., and Alessandro Riva, M.D., to its Board of Directors.
February 1, 2022
·
6 min read
Deals
Waters Acquires Charge Detection Mass Spectrometry Technology to Broaden its Application in Cell and Gene Therapy
Waters has acquired technology assets and intellectual property rights of Megadalton Solutions, an early-stage developer of charge detection mass spectrometry (CDMS).
February 1, 2022
·
2 min read
Subcutaneous Drug Delivery Devices Market Size and Forecast [2019-2029]
Subcutaneous drug delivery devices are gaining considerable traction over a brief period due to the convenience and comfort they provide to the consumer.
February 1, 2022
·
6 min read
Movable Imaging Displays Market: Rising Number of Surgical Procedures Is Expected to Drive the Market
Movable imaging display or mobile c arm is a medical imaging device based on X-ray technology and are used for a vast number of diagnostic imaging and minimally invasive procedures.
February 1, 2022
·
6 min read
Gynecology Lasers Market: The CO2 lasers segment is expected to dominate the market
Gynecology laser is a non-invasive energy-based technique, which has application in the treatment of various genital tract diseases in women.
February 1, 2022
·
6 min read
Internet of Things Technology Witnessing Increased Demand in Healthcare Industry due to Advantages of Remote Monitoring & Device Integration Functions
The healthcare industry has been constantly evolving over the years, with technological advancements improving the quality of services, offered by them to global population.
February 1, 2022
·
5 min read
Business
AVROBIO Announces the Appointment of Sean O’Bryan as Chief Regulatory Officer
AVROBIO, Inc. today announced the appointment of Sean O’Bryan as chief regulatory officer.
February 1, 2022
·
6 min read
Previous
9 of 23
Next